feed,title,long_url,short_url
InsiderMonkey,"Despite Slightly Disappointing Hospice Results, is Amedisys (AMED) Still A Smart Choice?",https://insidermonkey.com/blog/--1001620,
InsiderMonkey,Carillon Tower Thinks that Concerns Surrounding Fair Isaac (FICO) are ‘Overblown’,https://insidermonkey.com/blog/--1001623,
InsiderMonkey,Here’s What Makes Rush Street Interactive (RSI) A Great Investment Pick,https://insidermonkey.com/blog/--1001678,
InsiderMonkey,Here’s What Prompted Carillon Tower to Liquidate its Nevro Corp. (NVRO) Position,https://insidermonkey.com/blog/--1001686,
